Profil
Michael C.
Thompson currently works at DICE Therapeutics, Inc., as Treasurer & Director from 2023, Sigilon Therapeutics, Inc., as Treasurer & Director from 2023, and POINT Biopharma Global, Inc., as Treasurer & Director from 2023.
Aktive Positionen von Michael Thompson
| Unternehmen | Position | Beginn |
|---|---|---|
| DICE THER | Director/Board Member | 09.08.2023 |
| SIGILON THERAPEUTICS, INC. | Director/Board Member | 11.08.2023 |
| POIT BIOP | Director/Board Member | 27.12.2023 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| SIGILON THERAPEUTICS, INC. | Health Technology |
| POIT BIOP | Health Technology |
| Private Unternehmen | 1 |
|---|---|
DICE Therapeutics, Inc.
 DICE Therapeutics, Inc. BiotechnologyHealth Technology DiCE Therapeutics, Inc. is a biopharmaceutical company, which designs and develops a pipeline of novel oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. The company was founded by J. Kevin Judice on August 14, 2013 and is headquartered in South San Francisco, CA. | Health Technology |
